These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10864639)

  • 21. Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein.
    Neddermann P; Clementi A; De Francesco R
    J Virol; 1999 Dec; 73(12):9984-91. PubMed ID: 10559312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase.
    Attwood MR; Bennett JM; Campbell AD; Canning GG; Carr MG; Conway E; Dunsdon RM; Greening JR; Jones PS; Kay PB; Handa BK; Hurst DN; Jennings NS; Jordan S; Keech E; O'Brien MA; Overton HA; King-Underwood J; Raynham TM; Stenson KP; Wilkinson CS; Wilkinson TC; Wilson FX
    Antivir Chem Chemother; 1999 Sep; 10(5):259-73. PubMed ID: 10574181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.
    Gal-Tanamy M; Zemel R; Berdichevsky Y; Bachmatov L; Tur-Kaspa R; Benhar I
    J Mol Biol; 2005 Apr; 347(5):991-1003. PubMed ID: 15784258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of scFvs that inhibit the NS3 protease of hepatitis C virus by a combination of phage display and a bacterial genetic screen.
    Nahary L; Trahtenherts A; Benhar I
    Methods Mol Biol; 2009; 562():115-32. PubMed ID: 19554291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide.
    Urbani A; Biasiol G; Brunetti M; Volpari C; Di Marco S; Sollazzo M; Orrú S; Piaz FD; Casbarra A; Pucci P; Nardi C; Gallinari P; De Francesco R; Steinkühler C
    Biochemistry; 1999 Apr; 38(16):5206-15. PubMed ID: 10213628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of an in vitro assay to characterize hepatitis C virus NS3-4A protease trans-processing activity.
    Hamatake R; Wang HG; Butcher JA; Bifano M; Clark G; Hernandez D; Zhang S; Racela J; Standring D; Colonno R
    Intervirology; 1996; 39(4):249-58. PubMed ID: 9078466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RNA aptamer-binding site of hepatitis C virus NS3 protease.
    Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Shimotohno K; Taira K; Kusakabe I; Nishikawa S
    Biochem Biophys Res Commun; 2000 Dec; 279(2):557-62. PubMed ID: 11118325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of cell-based assays for in vitro characterization of hepatitis C virus NS3/4A protease inhibitors.
    Chung V; Carroll AR; Gray NM; Parry NR; Thommes PA; Viner KC; D'Souza EA
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1381-90. PubMed ID: 15793116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile.
    Martin MM; Condotta SA; Fenn J; Olmstead AD; Jean F
    Biol Chem; 2011 Oct; 392(10):927-35. PubMed ID: 21749281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
    McCoy MA; Senior MM; Gesell JJ; Ramanathan L; Wyss DF
    J Mol Biol; 2001 Feb; 305(5):1099-110. PubMed ID: 11162117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease.
    Taremi SS; Beyer B; Maher M; Yao N; Prosise W; Weber PC; Malcolm BA
    Protein Sci; 1998 Oct; 7(10):2143-9. PubMed ID: 9792101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: insights from molecular dynamics simulation, binding free energy calculation and network analysis.
    Xue W; Wang M; Jin X; Liu H; Yao X
    Mol Biosyst; 2012 Oct; 8(10):2753-65. PubMed ID: 22833015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of a hepatitis C virus NS3 protease-NS4A fusion protein in Escherichia coli.
    Inoue H; Sakashita H; Shimizu Y; Yamaji K; Yokota T; Sudo K; Shigeta S; Shimotohno K
    Biochem Biophys Res Commun; 1998 Apr; 245(2):478-82. PubMed ID: 9571178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential requirements of NS4A for internal NS3 cleavage and polyprotein processing of hepatitis C virus.
    Kou YH; Chang MF; Wang YM; Hung TM; Chang SC
    J Virol; 2007 Aug; 81(15):7999-8008. PubMed ID: 17522200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals.
    Franco S; Clotet B; Martínez MA
    Virus Res; 2008 Feb; 131(2):260-70. PubMed ID: 18037183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization.
    Koch U; Biasiol G; Brunetti M; Fattori D; Pallaoro M; Steinkühler C
    Biochemistry; 2001 Jan; 40(3):631-40. PubMed ID: 11170379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.